Both in Biotechnology
Sana Biotechnology vs Prime Medicine
Over the past year SANA returned −43.8% and PRME returned +3.5%; their daily moves had a correlation of 0.50.
SANA −43.8% PRME +3.5%Growth of $1, one year, split-adjusted
| Metric | SANA | PRME |
|---|---|---|
| Price | $2.57 | $4.72 |
| Market cap | $769.4M | $856.1M |
| Today | −5.51% | −9.92% |
| 1 month | −11.1% | +57.9% |
| 6 months | −21.4% | +38.4% |
| Year to date | −36.9% | +36.0% |
| 1 year | −52.1% | +4.0% |
| Revenue growth (YoY) | — | +3.5% |
| Gross margin | — | 100.0% |
| Net margin | — | −3649.0% |
| P/E (TTM) | — | — |
| Price / sales | — | 210.2× |
| Net cash | $160.5M | $95.1M |
| Dividend yield | — | — |
| Volatility (60d) | 72.0% | 111.1% |
| Short % of float | 22.2% | 34.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).